Doxorubicin Accord liposomal 20 mg/10 ml

Doxorubicin Accord liposomal 20 mg/10 ml is a medicine authorised by Swissmedic under authorisation number 68961. The authorisation holder is Accord Healthcare AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 January 2025 and the authorisation is limited until 08 January 2030. ATC code L01DB01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 68961
  • ATC L01DB01
  • Synthetic medicines
Authorisation data
Authorisation number68961
NameDoxorubicin Accord liposomal 20 mg/10 ml
Full nameDoxorubicin Accord liposomal 20 mg/10 ml, Konzentrat zur Herstellung einer Infusionsdispersion
Authorisation holderAccord Healthcare AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01DB01
First authorisation09 January 2025
Authorisation validity08 January 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Doxorubicin Accord liposomal 20 mg/10 ml, Konzentrat zur Herstellung einer InfusionsdispersionA09 January 2025
2Doxorubicin Accord liposomal 50 mg/25 ml, Konzentrat zur Herstellung einer InfusionsdispersionA09 January 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01DB0107.16.1.A
21Durchstechflasche(n)L01DB0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Doxorubicin Accord liposomal 20 mg/10 ml authorised in Switzerland?

Yes. Doxorubicin Accord liposomal 20 mg/10 ml is authorised by Swissmedic under authorisation number 68961, data as of 01 September 2026. The authorisation is limited until 08 January 2030.

Which dispensing category does Doxorubicin Accord liposomal 20 mg/10 ml have?

Doxorubicin Accord liposomal 20 mg/10 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Doxorubicin Accord liposomal 20 mg/10 ml?

The authorisation holder is Accord Healthcare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com